These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 1375700)

  • 61. Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis.
    Kantor TV; Whiteside TL; Friberg D; Buckingham RB; Medsger TA
    Arthritis Rheum; 1992 Jun; 35(6):694-9. PubMed ID: 1376124
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Relationship of large and small CD3- CD56+ lymphocytes mediating NK-associated activities.
    Ortaldo JR; Winkler-Pickett R; Kopp W; Kawasaki A; Nagashima K; Okumura K; Yagita H; Bach FH
    J Leukoc Biol; 1992 Sep; 52(3):287-95. PubMed ID: 1381742
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.
    Caligiuri MA; Murray C; Robertson MJ; Wang E; Cochran K; Cameron C; Schow P; Ross ME; Klumpp TR; Soiffer RJ
    J Clin Invest; 1993 Jan; 91(1):123-32. PubMed ID: 7678599
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibition of lymphokine-activated killer cells by human pulmonary macrophages: discordance between up-regulation of the beta chain (p75) of the interleukin-2 receptor on CD56+ cells and limited response to interleukin-2.
    Yarbrough WC; Wilkes DS; Weissler JC
    Am J Respir Cell Mol Biol; 1994 Feb; 10(2):184-91. PubMed ID: 7509162
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interleukin-2-activated murine cell lines with macrophage- and B-lymphoblast-lytic activity.
    Suzuki H; Ikemoto M; Yokoyama A; Kamitani T; Yamashita N; Maruyama M; Yano S
    Cell Immunol; 1991 Jan; 132(1):127-39. PubMed ID: 1829651
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
    Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G
    Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.
    Carson WE; Giri JG; Lindemann MJ; Linett ML; Ahdieh M; Paxton R; Anderson D; Eisenmann J; Grabstein K; Caligiuri MA
    J Exp Med; 1994 Oct; 180(4):1395-403. PubMed ID: 7523571
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Thymic origin of some natural killer cells: clonal proliferation of human CD3-16+ cells from CD3-4-8- thymocyte precursors requires the presence of H9 leukemic cells.
    Mingari MC; Poggi A; Bellomo R; Pella N; Moretta L
    Int J Clin Lab Res; 1991; 21(2):176-8. PubMed ID: 1840028
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function.
    Cambiaggi A; Orengo AM; Meazza R; Sforzini S; Tazzari PL; Lauria F; Raspadori D; Zambello R; Semenzato G; Moretta L; Ferrini S
    Blood; 1996 Mar; 87(6):2369-75. PubMed ID: 8630400
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Malignant clonal expansion of large granular lymphocytes with a Leu-11+, Leu-7- surface phenotype: in vitro responsiveness of malignant cells to recombinant human interleukin 2.
    Koizumi S; Seki H; Tachinami T; Taniguchi M; Matsuda A; Taga K; Nakarai T; Kato E; Taniguchi N; Nakamura H
    Blood; 1986 Nov; 68(5):1065-73. PubMed ID: 2945603
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro.
    Levitz SM; Dupont MP
    J Clin Invest; 1993 Apr; 91(4):1490-8. PubMed ID: 7682573
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Natural killer lines and clones with apparent antigen specificity.
    Suzuki N; Bianchi E; Bass H; Suzuki T; Bender J; Pardi R; Brenner CA; Larrick JW; Engleman EG
    J Exp Med; 1990 Aug; 172(2):457-62. PubMed ID: 2142719
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Establishment of a new natural killer (NK) cell line, TKS-1, from a patient with aggressive type of large granular lymphocyte (LGL) leukemia.
    Kojima H; Suzukawa K; Yatabe Y; Hori M; Nagasawa T; Abe T
    Leukemia; 1994 Nov; 8(11):1999-2004. PubMed ID: 7967745
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparative studies of CD3- and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression.
    Ortaldo JR; Winkler-Pickett RT; Yagita H; Young HA
    Cell Immunol; 1991 Sep; 136(2):486-95. PubMed ID: 1714795
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunomagnetic isolation of NK and LAK cells.
    Naume B; Nonstad U; Steinkjer B; Funderud S; Smeland E; Espevik T
    J Immunol Methods; 1991 Jan; 136(1):1-9. PubMed ID: 1704900
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 binding.
    Voss SD; Robb RJ; Weil-Hillman G; Hank JA; Sugamura K; Tsudo M; Sondel PM
    J Exp Med; 1990 Oct; 172(4):1101-14. PubMed ID: 1698909
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Phenotypic and genotypic heterogeneity in large granular lymphocyte expansion.
    Loiseau P; Divine M; Le Paslier D; Marolleau JP; Farcet JP; Flandrin G; Cohen D; Degos L; Sigaux F; Reyes F
    Leukemia; 1987 Mar; 1(3):205-9. PubMed ID: 3669743
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Patterns of CD16 and CD56 expression in persistent expansions of CD3+NKa+ lymphocytes are predictive for clonal T-cell receptor gene rearrangements. The Yorkshire Leukaemia Group.
    Sivakumaran M; Richards SJ; Hunt KM; Steed AJ; Bynoe AG; Morgan MM; Pyrah R; Roberts BE; Scott CS
    Br J Haematol; 1991 Jul; 78(3):368-77. PubMed ID: 1714758
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cytotoxicity of human natural killer (NK) cell subsets for Plasmodium falciparum erythrocytic schizonts: stimulation by cytokines and inhibition by neomycin.
    Orago AS; Facer CA
    Clin Exp Immunol; 1991 Oct; 86(1):22-9. PubMed ID: 1833100
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Functional and phenotypic assessment of neonatal human leucocytes expressing natural killer cell-associated antigens.
    Bradstock KF; Luxford C; Grimsley PG
    Immunol Cell Biol; 1993 Dec; 71 ( Pt 6)():535-42. PubMed ID: 7508887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.